Real-World Effectiveness of Dasatinib Versus Imatinib in Newly Diagnosed Patients With Chronic Myeloid Leukemia
Clinical Lymphoma Myeloma and Leukemia · 2024
DOI: 10.1016/j.clml.2023.10.005 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2024. Verfasst von Andrew J Klink und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cardinal Health Specialty Solutions, Dublin, OH. Electronic address: andrew.klink@cardinalhealth.com. Hauptthemen laut MEDLINE: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Bristol-Myers Squibb, Takeda Pharmaceuticals U.S.A..
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardinal Health Specialty Solutions, Dublin, OH. Electronic address: andrew.klink@cardinalhealth.com.
- Bristol Myers Squibb, Princeton, NJ.
- Cardinal Health Specialty Solutions, Dublin, OH.
- Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Förderung
- Bristol-Myers Squibb
- Takeda Pharmaceuticals U.S.A.
Zitieren
APA
Klink, A. J., Keating, S. J., Brokars, J., Feinberg, B., & Jabbour, E. (2024). Real-World Effectiveness of Dasatinib Versus Imatinib in Newly Diagnosed Patients With Chronic Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2023.10.005
Vancouver
Klink AJ, Keating SJ, Brokars J, Feinberg B, Jabbour E. Real-World Effectiveness of Dasatinib Versus Imatinib in Newly Diagnosed Patients With Chronic Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia. 2024. doi:10.1016/j.clml.2023.10.005
BibTeX
@article{Klink2024,
author = {Klink, Andrew J and Keating, Scott J and Brokars, John and Feinberg, Bruce and Jabbour, Elias},
title = {Real-World Effectiveness of Dasatinib Versus Imatinib in Newly Diagnosed Patients With Chronic Myeloid Leukemia},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2024},
doi = {10.1016/j.clml.2023.10.005}
}
EUVIMED